secwatch.observer — SEC 8-K summary
======================================

Issuer:     FOXO TECHNOLOGIES INC. (FOXO)
CIK:        0001812360
Form:       8-K
Filed at:   2025-09-15T23:59:59+00:00
Accession:  0001493152-25-013398
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.45
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

FOXO Technologies signs agreement to acquire Vector Biosource Inc.
------------------------------------------------------------------

- Purchase price: $500K cash, 60K Series E Preferred ($1.5M stated value), warrants for $2M common stock at 10% premium to closing price.
- Up to additional 80K Series E Preferred shares ($2M stated value) contingent on future revenue and cash collection milestones.
- FOXO to fund up to $1.2M for Vector's growth initiatives; Vector had Q2 2025 net revenue of ~$225K ($0.9M annualized).
- Closing subject to due diligence, finalization of warrant and employment agreements; expected as soon as practical.
- Vector provides data and biospecimen sourcing for biotech, clinical research, and pharma industries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225013398/0001493152-25-013398-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1812360/000149315225013398/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-013398

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer